Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study

[1] Xue AL(2017)Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis Medicine (Baltimore) 96 e6983-1214

[2] Wu SY(2016)Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study Rheumatol Int 36 1205-2419

[3] Jiang L(2011)High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis Osteoporos Int 22 2413-968

[4] Feng AM(2015)Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture Osteoporos Int 26 961-731

[5] Guo HF(2014)Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients J Bone Miner Metab 32 725-973

[6] Zhao P(2016)Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative Ann Rheum Dis 75 965-571

[7] Kim D(2015)Management of osteoporosis in rheumatoid arthritis patients Expert Opin Pharmacother 16 559-1087

[8] Cho SK(2019)Current treatments and new developments in the management of glucocorticoid-induced osteoporosis Drugs 79 1065-1005

[9] Choi CB(2017)Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study Rheumatol Int 37 999-487

[10] Jun JB(2019)Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates J Exp Orthop 6 41-2765

[1] Xue AL(2017)Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis Medicine (Baltimore) 96 e6983-1214

[2] Wu SY(2016)Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study Rheumatol Int 36 1205-2419

[3] Jiang L(2011)High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis Osteoporos Int 22 2413-968

[4] Feng AM(2015)Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture Osteoporos Int 26 961-731

[5] Guo HF(2014)Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients J Bone Miner Metab 32 725-973

[6] Zhao P(2016)Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative Ann Rheum Dis 75 965-571

[7] Kim D(2015)Management of osteoporosis in rheumatoid arthritis patients Expert Opin Pharmacother 16 559-1087

[8] Cho SK(2019)Current treatments and new developments in the management of glucocorticoid-induced osteoporosis Drugs 79 1065-1005

[9] Choi CB(2017)Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study Rheumatol Int 37 999-487

[10] Jun JB(2019)Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates J Exp Orthop 6 41-2765